Close-monitor your Competitor's Move, Request sample copy
Increasing Inorganic Growth StrategiesIncreasing adoption of inorganic growth strategies such as acquisition is expected to drive the market growth over the forecast period. For instance, on April 10, 2024, Myonex, a global clinical trial company, announced that it had acquired Saveway Compounding Pharmacy, a U.S.-based compounding pharmacy. The acquisition helps Myonex to better supply patients in clinical trials with medication and equipment as needed. It will also help the company expand its clinical trial designs and include direct-to-patient and home healthcare provider capabilities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients